Literature DB >> 8433888

Multiple acyl-coenzyme A dehydrogenation disorder responsive to riboflavin: substrate oxidation, flavin metabolism, and flavoenzyme activities in fibroblasts.

W Rhead1, V Roettger, T Marshall, B Amendt.   

Abstract

Multiple acyl-CoA dehydrogenation disorders result from generalized defects in intramitochondrial acyl-CoA dehydrogenation. Fibroblasts from a riboflavin-responsive multiple acyl-CoA dehydrogenation disorder patient catabolized 14C-butyrate, -octanoate, and -leucine normally after culture in riboflavin-supplemented medium (2 mg/L). After culture in riboflavin-depleted medium (< or = 1.4 micrograms/L), his cells oxidized the same substrates poorly at 20 to 33% of control (p < 0.05). Patient cells incubated in a wide range of D-[2-14C]riboflavin concentrations (3, 31.4, and 100 micrograms/L) synthesized 14C-flavin mononucleotide and 14C-flavin adenine dinucleotide (FAD) normally and had normal cytosolic 14C-flavin mononucleotide and 14C-FAD contents, which argues against defects in cellular riboflavin uptake and conversion to flavin mononucleotide and FAD. After culture in 31.4 micrograms 14C-riboflavin/L for 2 wk, 14C-FAD specific radioactivities plateaued and were similar in patient and control cells. However, culturing these uniformly labeled cells in riboflavin-depleted medium for 2 wk lowered the patient's cellular 14C-FAD content to only 23% of control levels. Similarly, after incubation in low 14C-riboflavin concentrations (4.4 micrograms/L), the patient's mitochondrial 14C-FAD content was only 51% of control after 1 h and 29% of control at 4 h. After a 4-h incubation in a high physiologic concentration of 14C-riboflavin (31.4 micrograms/L), which raised the patient's cellular 14C-FAD levels 3- to 4-fold, his mitochondrial 14C-FAD content rose to normal; control values did not change. We also investigated possible defective FAD binding to flavoenzymes essential for acyl-CoA dehydrogenation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433888     DOI: 10.1203/00006450-199302000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.

Authors:  Zhi-Qiang Wang; Xue-Jiao Chen; Shen-Xing Murong; Ning Wang; Zhi-Ying Wu
Journal:  J Mol Med (Berl)       Date:  2011-02-24       Impact factor: 4.599

2.  Synthesis and application of isotopically labeled flavin nucleotides.

Authors:  Tatiana V Mishanina; Amnon Kohen
Journal:  J Labelled Comp Radiopharm       Date:  2015-07-07       Impact factor: 1.921

3.  Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency.

Authors:  R K J Olsen; M Pourfarzam; A A M Morris; R C Dias; I Knudsen; B S Andresen; N Gregersen; S E Olpin
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect.

Authors:  Maria Sofia Cotelli; Valentina Vielmi; Marco Rimoldi; Manuela Rizzetto; Barbara Castellotti; Valeria Bertasi; Alice Todeschini; Valeria Gregorelli; Carla Baronchelli; Cinzia Gellera; Alessandro Padovani; Massimiliano Filosto
Journal:  Neurol Sci       Date:  2011-12-22       Impact factor: 3.307

5.  Mitochondrial fatty acid oxidation defects--remaining challenges.

Authors:  Niels Gregersen; Brage S Andresen; Christina B Pedersen; Rikke K J Olsen; Thomas J Corydon; Peter Bross
Journal:  J Inherit Metab Dis       Date:  2008-10-07       Impact factor: 4.982

6.  Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motif.

Authors:  Tze-Kiong Er; Chih-Chieh Chen; Yen-Yi Liu; Hui-Chiu Chang; Yin-Hsiu Chien; Jan-Gowth Chang; Jenn-Kang Hwang; Yuh-Jyh Jong
Journal:  BMC Struct Biol       Date:  2011-10-21

Review 7.  Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy.

Authors:  Maria Tolomeo; Alessia Nisco; Piero Leone; Maria Barile
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

8.  Bacterial Production, Characterization and Protein Modeling of a Novel Monofuctional Isoform of FAD Synthase in Humans: An Emergency Protein?

Authors:  Piero Leone; Michele Galluccio; Alberto Barbiroli; Ivano Eberini; Maria Tolomeo; Flavia Vrenna; Elisabetta Gianazza; Stefania Iametti; Francesco Bonomi; Cesare Indiveri; Maria Barile
Journal:  Molecules       Date:  2018-01-06       Impact factor: 4.411

Review 9.  Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.

Authors:  Signe Mosegaard; Graziana Dipace; Peter Bross; Jasper Carlsen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.